Tag

Bulk Drugs & API Manufacturing

2 articles

Gujarat Themis Biosyn FY26 PAT ₹46.68 Crores, Major Acquisitions

Gujarat Themis Biosyn reported FY26 total income of ₹168.25 crores with PAT of ₹46.68 crores and declared dividend of ₹0.67 per share. Company expanded fermentation capacity from 450 KL to 990 KL and

Gujarat Themis Biosyn FY26 Net Profit ₹466.8 Crore

Gujarat Themis Biosyn reported audited FY26 results with net profit of ₹466.8 crore on revenue of ₹1,658.2 crore, approved by board on May 25, 2026. Company significantly expanded operations with ₹4,5